129 related articles for article (PubMed ID: 18776074)
21. Improved care of type 2 diabetes patients as a result of the introduction of a practice nurse: 2003-2007.
den Engelsen C; Soedamah-Muthu SS; Oosterheert NJ; Ballieux MJ; Rutten GE
Prim Care Diabetes; 2009 Aug; 3(3):165-71. PubMed ID: 19726260
[TBL] [Abstract][Full Text] [Related]
22. [AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care].
Gruppo di studio ANNALI AMD
Epidemiol Prev; 2011; 35(1):18-26. PubMed ID: 21436491
[TBL] [Abstract][Full Text] [Related]
23. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
24. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
[TBL] [Abstract][Full Text] [Related]
25. Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.
Voorham J; Haaijer-Ruskamp FM; van der Meer K; de Zeeuw D; Wolffenbuttel BH; Hoogenberg K; Denig P;
Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1078-86. PubMed ID: 20687048
[TBL] [Abstract][Full Text] [Related]
26. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
[TBL] [Abstract][Full Text] [Related]
27. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
[TBL] [Abstract][Full Text] [Related]
28. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
Clifford RM; Davis WA; Batty KT; Davis TM;
Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
[TBL] [Abstract][Full Text] [Related]
29. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
[TBL] [Abstract][Full Text] [Related]
30. Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.
Braga MF; Casanova A; Teoh H; Gerstein HC; Fitchett DH; Honos G; McFarlane PA; Ur E; Yale JF; Langer A; Goodman SG; Leiter LA;
Int J Clin Pract; 2012 May; 66(5):457-64. PubMed ID: 22452524
[TBL] [Abstract][Full Text] [Related]
31. Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Aschner P; Chan J; Owens DR; Picard S; Wang E; Dain MP; Pilorget V; Echtay A; Fonseca V;
Lancet; 2012 Jun; 379(9833):2262-9. PubMed ID: 22683131
[TBL] [Abstract][Full Text] [Related]
32. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
[TBL] [Abstract][Full Text] [Related]
33. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
Charpentier G; Halimi S;
Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
[TBL] [Abstract][Full Text] [Related]
34. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
[TBL] [Abstract][Full Text] [Related]
35. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
[TBL] [Abstract][Full Text] [Related]
36. Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study.
Crasto W; Jarvis J; Khunti K; Skinner TC; Gray LJ; Brela J; Troughton J; Daly H; Lawrence IG; McNally PG; Carey ME; Davies MJ
Diabetes Res Clin Pract; 2011 Sep; 93(3):328-36. PubMed ID: 21640424
[TBL] [Abstract][Full Text] [Related]
37. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Bays HE; Goldberg RB; Truitt KE; Jones MR
Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
[TBL] [Abstract][Full Text] [Related]
38. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
[TBL] [Abstract][Full Text] [Related]
39. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
[TBL] [Abstract][Full Text] [Related]
40. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
